T1	Patho_physiology 242 262	cellular homeostasis
E1	Patho_physiology:T1 Agent:T7
T2	Patho_physiology 267 286	immune surveillance
E2	Patho_physiology:T2 Agent:T7
T3	Entity 26 31	TRAIL
T4	Entity 32 36	-716
T5	Entity 37 40	C/T
T6	Entity 41 49	promoter
T7	SNP 50 62	polymorphism
R1	SNP_location Arg1:T7 Arg2:T6	
R2	Nucleotide_substitution Arg1:T7 Arg2:T5	
R3	SNP_location Arg1:T7 Arg2:T4	
R4	SNP_coupled_gene Arg1:T7 Arg2:T3	
T8	Association 110 124	susceptibility
E3	Association:T8 snp_int:T7 snp_int2:T9
T9	Cancer 128 149	sporadic breast tumor
T10	Entity 332 334	CC
T11	Entity 347 351	-716
T12	SNP 367 370	SNP
T13	Entity 358 366	promoter
T14	Entity 352 357	TRAIL
R5	SNP_location Arg1:T12 Arg2:T13	
R6	SNP_coupled_gene Arg1:T12 Arg2:T14	
R7	SNP_location Arg1:T12 Arg2:T11	
R8	Genotype Arg1:T12 Arg2:T10	
T15	Association 380 384	risk
E4	Association:T15 bc:T16 snp_int:T12
T16	Cancer 389 411	sporadic breast cancer
A1	Cancer_Type T16 Non_hereditary
A2	Cancer_Type T9 Non_hereditary
E5	Association:T15 snp_int:T21 snp_int2:T20 bc:T16
T17	Neg 412 426	as compared to
T18	Entity 431 433	CT
T19	Entity 438 440	TT
T20	SNP 367 370	SNP
T21	SNP 367 370	SNP
R9	Negation_marker Arg1:E5 Arg2:T17	
R10	Genotype Arg1:T21 Arg2:T18	
R11	Genotype Arg1:T20 Arg2:T19	
R12	SNP_location Arg1:T20 Arg2:T13	
R13	SNP_location Arg1:T21 Arg2:T13	
R14	SNP_location Arg1:T21 Arg2:T11	
R15	SNP_location Arg1:T20 Arg2:T11	
R16	SNP_coupled_gene Arg1:T20 Arg2:T14	
R17	SNP_coupled_gene Arg1:T21 Arg2:T14	
T22	Gene_Regulation 933 950	transcriptionally
E6	Gene_Regulation:T22 
T23	Effect_Type 951 960	repressed
A3	Effect_Type E6 Decrease
R18	Effect_type_marker Arg1:E6 Arg2:T23	
T24	SNP 367 370	SNP
T25	Entity 971 975	-716
R19	SNP_location Arg1:T24 Arg2:T25	
T26	Entity 976 977	T
R20	SNP_allele Arg1:T24 Arg2:T26	
E7	Gene_Regulation:T22 
T27	Entity 995 999	-716
T28	SNP 367 370	SNP
R21	SNP_location Arg1:T28 Arg2:T27	
T29	Entity 1000 1001	C
R22	SNP_allele Arg1:T28 Arg2:T29	
R23	SNP_coupled_gene Arg1:T24 Arg2:T14	
R24	SNP_coupled_gene Arg1:T28 Arg2:T14	
R25	SNP_location Arg1:T24 Arg2:T13	
R26	SNP_location Arg1:T28 Arg2:T13	
T30	Interaction 1014 1034	SNP-SNP interactions
E8	Interaction:T30 Entity3:T34 Entity2:T21 Entity:T20
T31	Effect_Type 1048 1056	enhanced
T32	Association 1057 1074	protective effect
E9	Association:T32 snp_int:E8 bc:T16
T33	Entity 1141 1151	TP53-BRCA2
R27	Risk_Factor Arg1:E8 Arg2:T33	
T34	SNP 1254 1261	variant
T35	Entity 1262 1267	Casp8
R28	SNP_coupled_gene Arg1:T34 Arg2:T35	
T36	Association 1370 1385;1396 1405	overrepresented genotypes
E10	Association:T36 bc:T37 bc2:T38 snp_int:T21 snp_int2:T20
T37	Cancer 1409 1420;1452 1458	progressing tumors
T38	Cancer 1437 1458	ER/PR negative tumors
A4	Cancer_Type T38 Horm-ve_other
A5	Cancer_Type T37 Other
R29	Effect_type_marker Arg1:E9 Arg2:T31	
A6	Effect_Type E9 Increase
T39	Effect_Type 1500 1509	increased
T40	Other_effect 1510 1525	apoptotic index
E11	Other_effect:T40 Agent:T12
A7	Effect_Type E11 Increase
T41	Entity 1804 1812	promoter
T42	SNP 1813 1816	SNP
T43	Entity 1820 1825	TRAIL
R31	SNP_location Arg1:T42 Arg2:T41	
R32	SNP_coupled_gene Arg1:T42 Arg2:T43	
T44	Gene_Regulation 1839 1848	modulates
E12	Gene_Regulation:T44 Theme:T43 Agent:T42
T45	Association 1879 1883	role
E13	Association:T45 bc:T46 snp_int:T42
T46	Cancer 1887 1900	breast cancer
T47	SNP 1953 1956	SNP
T48	Entity 1987 2000	TRAIL therapy
R33	Risk_Factor Arg1:T47 Arg2:T48	
T49	Entity 1942 1946	-716
T50	Entity 1947 1952	TRAIL
R34	SNP_coupled_gene Arg1:T47 Arg2:T50	
R35	SNP_location Arg1:T47 Arg2:T49	
R36	Equiv Arg1:T42 Arg2:T12	
R30	Effect_type_marker Arg1:E11 Arg2:T39	
A8	SNP_Class T34 Common_variant
